Literature DB >> 10023012

Prognostic factors in colorectal cancer.

J P Cerottini1, S Caplin, S Pampallona, J C Givel.   

Abstract

Prognosis of patients after colorectal cancer resection is predominantly influenced by the extent of local tumour growth and the presence or absence of nodal or distant metastasis. However, many factors have been used to generate numerous classification systems, leading to some debate and confusion. The effects on survival of 7 clinical and pathological parameters were reviewed in 801 consecutive patients operated upon with locally curative intent for colorectal cancer over a ten-year period. Age less than 50 or more than 70 years, poor cellular differentiation, high mucous secretion by tumour cells and Dukes' staging were the parameters significantly correlated to poor overall survival (p<0.001 for each). The Cox's regression analysis identified the same parameters as independent prognostic factors. The value of age as a prognostic factor remains debatable, but the other three parameters must be considered when evaluating prognosis after curative surgery for colorectal cancer and when considering adjuvant therapy.

Entities:  

Mesh:

Year:  1999        PMID: 10023012     DOI: 10.3892/or.6.2.409

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  Expression of cortactin correlates with a poor prognosis in patients with stages II-III colorectal adenocarcinoma.

Authors:  Jian-hua Cai; Ren Zhao; Jian-wei Zhu; Xiao-long Jin; Fang-jun Wan; Kun Liu; Xiao-pin Ji; Yan-bo Zhu; Zheng-gang Zhu
Journal:  J Gastrointest Surg       Date:  2010-06-08       Impact factor: 3.452

2.  Impact of chemotherapy-related prognostic factors on long-term survival in patients with stage III colorectal cancer after curative resection.

Authors:  Wen-Sy Tsai; Pao-Shiu Hsieh; Chien-Yuh Yeh; Jy-Ming Chiang; Reiping Tang; Jinn-Shiun Chen; Chung Rong Changchien; Jeng Yi Wang
Journal:  Int J Clin Oncol       Date:  2012-01-20       Impact factor: 3.402

3.  Clinical significance of a microRNA signature for the identification and predicting prognosis in colorectal cancers with mucinous differentiation.

Authors:  Juan Ruiz-Bañobre; Roshni Roy; Miren Alustiza Fernández; Óscar Murcia; Rodrigo Jover; Miguel Pera; Francesc Balaguer; Rafael López-López; Ajay Goel
Journal:  Carcinogenesis       Date:  2020-11-13       Impact factor: 4.944

4.  Real-world study of a novel prognostic scoring system: for a more precise prognostication and better clinical treatment guidance in stages II and III colon cancer.

Authors:  Qi Liu; Yanlei Ma; Dakui Luo; Sanjun Cai; Qingguo Li; Xinxiang Li
Journal:  Int J Colorectal Dis       Date:  2018-05-16       Impact factor: 2.571

5.  TES inhibits colorectal cancer progression through activation of p38.

Authors:  Huili Li; Kun Huang; Lu Gao; Lixia Wang; Yanfeng Niu; Hongli Liu; Zheng Wang; Lin Wang; Guobin Wang; Jiliang Wang
Journal:  Oncotarget       Date:  2016-07-19

6.  Five-year follow-up study of stage I-IV rectal cancer including EGFR immunoexpression and p21 immunoactivity.

Authors:  Monika Kozłowska-Geller; Stanisław Głuszek; Piotr Lewitowicz
Journal:  Prz Gastroenterol       Date:  2021-03-31

7.  New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer.

Authors:  P G Gobbi; F Valentino; E Berardi; C Tronconi; S Brugnatelli; O Luinetti; R Moratti; G R Corazza
Journal:  Br J Cancer       Date:  2007-11-20       Impact factor: 7.640

8.  P-TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management.

Authors:  Qi Liu; Dakui Luo; Sanjun Cai; Qingguo Li; Xinxiang Li
Journal:  Cancer Manag Res       Date:  2018-07-31       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.